扬子晚报网12月22日讯(通讯员钱小蔷记者万凌云姜天圣)近日，江苏省总工会、江苏省人力资源和社会保障厅联合发文《关于表彰2025年江苏省五一劳动 奖、江苏省工人先锋号和江苏省五一巾帼标兵的决定》，江苏大学附属医院荣获江苏省五一劳动奖状，是镇江市唯一获此殊荣的医疗机构。 | | 100 / 1 / 1 / 1 / 1 / 4 / 4 / 4 / 4 / | | --- | --- | | 2025年江苏省五一劳动奖、 | 晶澳(扬州)太阳能科技有限公司 | | 江苏省工人先锋号和江苏省五一中帼标兵名单 | 扬州三湾投资发展有限公司 | | | 江苏金材科技有限公司 | | 江苏省五一劳动奖状 | 江苏优士化学有限公司 | | | 江苏天润环境建设集团有限公司 | | 江苏柯菲平医药股份有限公司 | 扬州市树人高级中学(原扬州中学教育集团树人学校 | | 利安人寿保险股份有限公司 | 扬州泰州国际机场投资建设有限责任公司 | | 南京巨鲨显示科技有限公司 | 扬州中远海运重工有限公司 | | 江苏星宇芯联电子科技有限公司 | 扬州市国家安全局 | | 南京乐我家政服务有限公司 | 丹阳市丹北镇人民政府 | | 江 ...

经初步检查，急救团队发现：小娜依拉体重仅1.6公斤，属于极低出生体重儿，伴有肺动脉高压、低钙 血症、贫血等多种病症，且呼吸困难、心肺功能差等问题时刻威胁着脆弱的生命。 转入石大一附院新生儿监护室后，医护团队迅速制定出个性化救治方案，在先进的生命支持设备保障 下，对患儿展开24小时精细化监护与治疗。此后，历经重重难关，小娜依拉的生命体征逐渐平稳下来， 各项关键指标陆续恢复正常。 之后，医护团队又为小娜依拉精心设计了个性化康复方案：指导家属进行"袋鼠式护理"，通过亲子皮肤 接触给予宝宝温暖与安全感；科学规划、循序渐进地引入母乳喂养，耐心锻炼其吸吮吞咽能力，帮助小 娜依拉逐步建立自主进食的生理机能。 在医护人员与家长的共同努力下，目前，小娜依拉的体重已增至2.88公斤，身体日渐红润强壮。 "这场跨越空间的极速驰援，成功完成了兵团胎龄最小危重早产儿的空中转运，凸显出兵团航空医疗救 援体系的高效与专业。"石大一附院相关负责人表示。 ●兵团日报全媒体记者 郑娅莉 通讯员 权江宏 "谢谢你们，是你们给了我的孩子第二次生命。"12月13日，在石河子大学第一附属医院新生儿监护室， 小娜依拉（化名）的母亲紧紧拉着医护人员的手表达 ...

Group 1 - HCA Healthcare, Inc. operates a network of 190 hospitals and approximately 2,400 ambulatory care sites, with a significant reduction in share count by 44% since the end of 2015 [1] - The stock reached new all-time highs last month but has since pulled back nearly $50 without a specific reason, indicating a potential buying opportunity [1] - L1 Capital has reduced its investment in HCA Healthcare due to strong share price appreciation, although it remains a retained investment, no longer a top 10 holding [2] Group 2 - The market has previously reacted pessimistically to potential regulatory developments affecting HCA, creating opportunities for investment at attractive price levels [2] - Current expectations for operating conditions are more balanced, and the share price has increased significantly, leading to a less favorable risk-adjusted return potential from the current price [2] - There is a belief that certain AI stocks may offer greater upside potential and carry less downside risk compared to HCA [2]

【#2名患者体内钻头遗留医院被罚3万#】#2名患者体内遗留钻头数月仍未获赔#"我今年3月11日在祁阳 市中医医院做的骨科手术，过程中医生把钻头打断了，直接掉在我的骨缝里，可这件事他们从头到尾都 没跟我和家属提过一句。"12月16日，因意外跌伤接受手术的周外平面对记者时激动地回忆说。据他讲 述，自出院后，手术的右腿就一直疼。他一次次找主治医生反映情况，甚至在五个月里反复跑医院复查 了好几次，就想弄清疼的原因。可每次得到的答复都如出一辙："术后恢复期疼痛很正常，可能是你个 人体质差，恢复得慢"。这样的情况一直持续到9月。忍无可忍的周外平转去另一家医院检查，结果让他 大吃一惊。医生告诉他，右腿的手术部位嵌着一枚断裂的钻头。而在此前的一个多月，与周外平同病 房、同一天接受手术的患者柏系生，也是一模一样的遭遇。其左小腿术后疼痛不止，经外院检查确认， 体内同样遗留着一颗手术钻头。周外平气愤地告诉记者，直到9月15日，他才拿到一份由蒋国贤等手术 组人员签字的《证明》。该《证明》上明确记载：周外平体内遗留断裂钻头1枚，术后未告知本人及家 属，情况属实。#院方称患者体内被遗落钻头影响不大# 祁阳市中医医院党委委员周伟接受采访时 ...

2025.12. 20 "这个问题到底怎么处理，什么时候处理，医院总得给我们一个说法吧？"周外平气愤地表示，直到9月15日，他才拿到一份由蒋国贤等手术组人员签字 的《证明》。该《证明》上明确记载：周外平体内遗留断裂钻头1枚，术后未告知本人及家属，情况属实。 为何刻意隐瞒这一医疗事故？祁阳市中医医院党委委员周伟在接受采访时解释，医院确认手术中钻头断裂遗落体内一事属实，但当时认为"对患者影响不 大"，计划在后续取钢板手术时一并处理，因此未及时告知。 他还表示，永州市卫健委已于2025年11月25日对该医院及相关医师作出行政处罚。相关《行政处罚决定书》指出，2名卫生监督人员对患者柏系生手术 中钻头断裂一事进行调查，医院存在"未按规定告知患者医疗风险、替代医疗方案等情况并取得其书面同意""未按规定填写病历资料"等违法行为，对医 院给予警告并罚款3万元，同时责令立即改正相关违法行为。 本文字数：1374，阅读时长大约2分钟 来源 | 南国今报 同一病房、两名患者，同一天手术竟都被遗落钻头在体内！据媒体报道， 在湖南省祁阳市中医医院进行骨科手术后持续疼痛，多次复查却被告知是正常 的，直到换了一家医院才得知真相。 "我今年 ...

优化资源配置，国家区域医疗中心投入运行，国家中医区域医疗中心年内完成主体建设，3个省级区域 医疗中心年内陆续落地。青海省人民医院、青海大学附属医院等4家省内三甲医院与北京中日友好医院 等高水平医院签约共建，借力提升专科实力。依托青海省妇女儿童医院组建专科联盟，上联国内顶尖儿 科医院，下联全省43家医疗机构，基层儿科服务能力明显提升。建成覆盖省、市州、县、乡四级的远程 诊疗和教育平台，累计开展远程会诊2963次、双向转诊8340例，远程影像和心电诊断超4.7万例。 全省组建各类医联体120个，县域医共体实现39个县（市、区）全覆盖。39家县级医院达到国家服务能 力基本标准，增幅居全国第二。建成医学影像、心电诊断、医学检验等县域医疗中心67个，71.14%的 基层机构达到国家服务能力标准，其中：36.82%的机构达到国家推荐标准。17家省垣医院下沉西宁市 23家基层机构，服务覆盖157.05万主城区人口，累计派出专家414人次，服务群众2.59万人次，基层就诊 比例提升12.79%。30个县实现乡级派驻、村级巡诊全覆盖，共派驻中级及以上医师155人，诊疗服务3 万余人次。西宁市与玉树州9个基层医疗机构建立结对共建 ...

Core Viewpoint - Edelson Lechtzin LLP is investigating Ardent Health, Inc. for potential violations of federal securities laws due to allegations of misleading business information provided to investors [1]. Company Overview - Ardent Health, founded in 2001, operates a network of 30 hospitals and over 280 care locations across six states, catering to mid-sized communities with a diverse range of healthcare services [2]. Alleged Wrongdoing - On November 12, 2025, Ardent Health reported third-quarter results that did not meet expectations, primarily due to an increase in insurance claim denials and a $54 million adjustment related to prior claims and litigation in New Mexico involving a former provider [3]. - The company revised its accounting estimates, leading to an earlier recognition of reserves, which resulted in a $43 million reduction in reported revenue for the quarter [3]. - Following this announcement, Ardent Health's stock price dropped by over 33% on November 13, 2025 [4].

Core Insights - Universal Health Services, Inc. (UHS) is identified as a compelling value play in the medical facilities sector, trading at a forward earnings multiple of 9.62X, which is below its five-year median of 11.70X and the industry average of 10.84X [1][6] - UHS has a Value Score of A, indicating strong appeal to valuation-conscious investors [2] Share Price Performance - UHS has seen a share price increase of 26.7% over the past year, outperforming the industry growth of 22.1% and the S&P 500's rise of 16.3% [4] - Despite trailing behind Tenet Healthcare Corporation (THC) and HCA Healthcare, Inc. (HCA) in returns, UHS has still achieved significant gains, reflecting improving fundamentals and investor confidence [4] Financial Metrics - UHS's forward P/E ratio of 9.62X is lower than major peers, with rising admissions and patient days supporting revenue growth [6] - Adjusted net margins have expanded from 5.2% in 2023 to 7.1% in 2024 and further to 8.1% in Q3 2025, indicating operational leverage [10] Revenue Growth - UHS has experienced steady revenue growth across its Acute Care Hospital Services and Behavioral Health Care Services segments, with adjusted admissions increasing by 6.5% in 2023 and projected growth of 3.8% in 2024 [9] - Adjusted patient days in the Behavioral Health segment rose by 1.7% in 2023 and 1.6% in 2024, demonstrating stable demand [9] Cash Flow and Shareholder Returns - UHS generated $525 million in free cash flow in 2023, $1.1 billion in 2024, and $537 million in the first nine months of 2025, with a conservative long-term debt-to-capital ratio of 35.7% [11] - The company has repurchased approximately 36% of its outstanding shares since 2019, with buybacks totaling $525 million in 2023 and $598.5 million in 2024 [12] Earnings Estimates - The Zacks Consensus Estimate for 2025 adjusted earnings is $21.83 per share, indicating a year-over-year growth of 31.4%, with a projected 7.4% increase in 2026 [13] - Revenue estimates imply growth of 9.7% in 2025 and 5.2% in 2026, with UHS exceeding earnings expectations in the past four quarters, delivering an average surprise of 15.2% [14][13] Analyst Sentiment - Analysts suggest additional upside for UHS shares, which currently trade below the average price target of $252.18, indicating potential upside of approximately 12.1% [15] - Target estimates range from $190 to $302, reflecting varying risk assumptions, but the overall outlook remains positive [15] Conclusion - UHS is well-positioned for investors seeking value with improving fundamentals, supported by discounted valuation, consistent volume growth, expanding margins, and strong free cash flow generation [16] - The company has a conservative balance sheet and an aggressive share repurchase program, enhancing shareholder returns [16]

Somerset Indus Capital Partners, a healthcare-focused private equity (PE) company, has announced an investment in NU Hospitals, an India-based speciality hospital chain that provides nephrology and urology care. The amount of investment has not been divulged by either party This transaction represents Somerset Indus Capital Partners’ third investment from its third fund. Established in 1999, NU Hospitals specialises in nephrology, urology, fertility, and renal transplant services. The investment from ...

Healthcare Pricing - US hospitals are marking up old cancer treatments significantly [1] - Markups are sometimes hundreds of times what Medicare pays [1]